Rapid Micro Biosystems Inc Revenue Growth Rates (RPID), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Rapid Micro Biosystems Inc   (NASDAQ: RPID)
 

RPID's Revenue Growth by Quarter and Year

Rapid Micro Biosystems Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RPID Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 8.05
1st Quarter March 7.37
FY 15.42

RPIDs Annual Revenue
Rapid Micro Biosystems Inc 's Revenue in the fiscal year 2025 $ 33.59 millions
Rapid Micro Biosystems Inc 's Revenue in the fiscal year 2024 $ 28.05 millions
Rapid Micro Biosystems Inc 's Revenue in the fiscal year 2023 $ 22.52 millions
Rapid Micro Biosystems Inc 's Revenue in the fiscal year 2022 $ 17.13 millions
Rapid Micro Biosystems Inc 's Revenue in the fiscal year 2021 $ 23.23 millions




RPID Revenue second quarter 2026 Y/Y Growth Comment
Rapid Micro Biosystems Inc reported Revenue increase of 10.94% year on year in the second quarter 2026, to $ 8.05 millions, this is lower than Rapid Micro Biosystems Inc 's recent average Revenue increase of 16.39%.

Looking into second quarter 2026 results within Laboratory Analytical Instruments industry 3 other companies have achieved higher Revenue growth. While Rapid Micro Biosystems Inc ' s Revenue growth of 10.94% ranks overall at the positon no. 1639 in the second quarter 2026.


RPID Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 37.23 % 29.65 % 45.08 %
3rd Quarter September - 3.16 % 23.58 % 29.75 %
2nd Quarter June 10.94 % 9.67 % 32.4 % 29.53 %
1st Quarter March 2.22 % 28.52 % 11.31 % 21.15 %
FY   - 19.75 % 24.5 % -

Financial Statements
Rapid Micro Biosystems Inc 's second quarter 2026 Revenue $ 8.05 millions RPID's Income Statement
Rapid Micro Biosystems Inc 's second quarter 2025 Revenue $ 7.26 millions Quarterly RPID's Income Statement


RPID Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 43.88 % 8.16 % 3.09 %
3rd Quarter September - 7.99 % 14.8 % 23 %
2nd Quarter June 9.28 % 0.69 % 18 % -0.79 %
1st Quarter March -34.66 % -12.29 % -11.51 % 15.33 %
FY (Year on Year)   - 19.75 % 24.5 % -


Back to RPID Growth rate Comparisons >> Back to RPID Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #4
Healthcare Sector #267
Overall #1639

Revenue Y/Y Growth Statistics
High Average Low
136.41 % 16.39 % -37.03 %
(Jun 30 2023)   (Mar 31 2026)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #4
Healthcare Sector #267
Overall #1639
Revenue Y/Y Growth Statistics
High Average Low
136.41 % 16.39 % -37.03 %
(Jun 30 2023)   (Mar 31 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Rapid Micro Biosystems Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
102.35 % 8.47 % -39.36 %
(Sep 30 2020)  


RPID's II. Quarter Q/Q Revenue Comment
Rapid Micro Biosystems Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 9.28%, to $ 8.05 millions, from $7.37 millions in the first quarter.
RPID is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Rapid Micro Biosystems Inc 's Revenue growth quarter on quarter, overall rank is 827.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #126
Overall #827
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #126
Overall #827
Revenue Q/Q Growth Statistics
High Average Low
102.35 % 8.47 % -39.36 %
(Sep 30 2020)  


RPID's II. Quarter Q/Q Revenue Comment
Rapid Micro Biosystems Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 9.28%, to $ 8.05 millions, from $7.37 millions in the first quarter.
RPID is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Rapid Micro Biosystems Inc 's Revenue growth quarter on quarter, overall rank is 827.


Rapid Micro Biosystems Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 34.55 $ 33.75 $ 33.59 $ 30.52 $ 30.29
Y / Y Revenue Growth (TTM) 14.05 % 13.86 % 19.74 % 16.63 % 22.57 %
Year on Year Revenue Growth Overall Ranking # 542 # 385 # 263 # 179 # 317
Seqeuential Revenue Change (TTM) 2.35 % 0.49 % 10.04 % 0.77 % 2.17 %
Seq. Revenue Growth (TTM) Overall Ranking # 1868 # 1763 # 1406 # 690 # 1165


Cumulative Revenue growth Comment
Although Rapid Micro Biosystems Inc 's Annual Revenue growth year on year were below company's average 134.22% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 14.05% year on year, from 13.86% in Mar 31 2026.

In the Healthcare sector 125 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 385 to 542.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 7
Healthcare Sector # 126
Overall # 542

Revenue TTM Y/Y Growth Statistics
High Average Low
913.23 %
 134.22 %
13.86 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 289
S&P 500 # 1868
Cumulative Revenue growth Comment
Although Rapid Micro Biosystems Inc 's Annual Revenue growth year on year were below company's average 134.22% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 14.05% year on year, from 13.86% in Mar 31 2026.

In the Healthcare sector 125 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 385 to 542.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 7
Healthcare Sector # 126
Overall # 542

Revenue TTM Y/Y Growth Statistics
High Average Low
913.23 %
134.22 %
13.86 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 289
S&P 500 # 1868




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RPID's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bioaffinity Technologies Inc 18.99%$ 18.992 millions
Aurinia Pharmaceuticals Inc 18.87%$ 18.872 millions
Camp4 Therapeutics Corporation18.84%$ 18.838 millions
Lensar Inc 18.37%$ 18.371 millions
Immunocore Holdings Plc18.34%$ 18.336 millions
Innovage Holding Corp 18.31%$ 18.307 millions
Koru Medical Systems Inc 18.15%$ 18.153 millions
Clearpoint Neuro Inc 18.07%$ 18.068 millions
Avita Medical Inc 17.83%$ 17.830 millions
Xencor Inc17.46%$ 17.458 millions
Logicmark Inc17.39%$ 17.387 millions
Ensign Group Inc17.33%$ 17.325 millions
Medpace Holdings Inc 17.24%$ 17.242 millions
Geron Corporation17.22%$ 17.220 millions
Si bone inc 17.16%$ 17.159 millions
Cvrx inc 16.77%$ 16.766 millions
Regeneron Pharmaceuticals Inc 16.73%$ 16.735 millions
Invo Fertility Inc 16.73%$ 16.732 millions
Pro dex Inc 16.65%$ 16.646 millions
Royalty Pharma Plc16.50%$ 16.499 millions
Acadia Pharmaceuticals Inc 16.40%$ 16.402 millions
Harvard Bioscience Inc 16.35%$ 16.352 millions
Alpha Pro Tech Ltd 15.76%$ 15.765 millions
Armata Pharmaceuticals Inc 15.72%$ 15.722 millions
Lifeward ltd 15.71%$ 15.706 millions
Novocure Limited15.60%$ 15.603 millions
Ufp Technologies Inc 15.56%$ 15.558 millions
Orthopediatrics Corp15.55%$ 15.551 millions
Jazz Pharmaceuticals Plc15.55%$ 15.548 millions
Alphatec Holdings Inc 15.35%$ 15.349 millions


About Rapid Micro Biosystems Inc Revenue Growth Rates (RPID), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Rapid Micro Biosystems Inc (CIK 1380106).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001380106-26-000101
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Rapid Micro Biosystems Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.